RAAS Inhibitors and Risk of Covid-19

被引：0
|
作者：
Islam, Nazrul [1 ]
Khunti, Kamlesh [2 ]
Chowell, Gerardo [3 ]
机构：
[1] Univ Oxford, Oxford, England
[2] Univ Leicester, Leicester, Leics, England
[3] Georgia State Univ, Atlanta, GA 30303 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 383卷 / 20期
关键词：
ACE2;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1992 / 1992
页数：1
相关论文
共 50 条
  • [31] Risk of COVID-19 in Patients Taking Proton Pump Inhibitors
    Hadi, Yousaf B.
    Naqvi, Syeda Fatima
    Kupec, Justin T.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (11): : 1919 - 1920
  • [32] The Interplay Between the Immune System, the Renin-Angiotensin-Aldosterone System (RAAS), and RAAS Inhibitors May Modulate the Outcome of COVID-19: A Systematic Review
    Naveed, Hiba
    Elshafeey, Abdallah
    Al-Ali, Dana
    Janjua, Emmad
    Nauman, Areej
    Kawas, Hussam
    Kaul, Ridhima
    Saed Aldien, Arwa
    Elshazly, Mohamed B.
    Zakaria, Dalia
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (08): : 987 - 1000
  • [33] The effect of RAAS inhibitors on acute hypoxemic respiratory failure and in-hospital mortality in the hypertensive Covid-19 patients
    Akyuz, Abdurrahman
    Isik, Ferhat
    Aslan, Burhan
    Cap, Murat
    Kaya, Ilyas
    Atli, Ozgur
    Inci, Umit
    Tastan, Ercan
    Aktan, Adem
    Bilge, Onder
    Oksul, Metin
    Aydin, Emre
    Karahan, Zulkuf
    Altintas, Derya Deniz
    Altindag, Rojhat
    Adiyaman, Mehmet Sahin
    Altintas, Bernas
    [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION, 2021, 43 (07) : 587 - 596
  • [34] Calcineurin Inhibitors and COVID-19
    Hage, Rene
    Schuurmans, Mace M.
    [J]. REUMATOLOGIA CLINICA, 2022, 18 (05): : 314 - 315
  • [35] JAK inhibitors and COVID-19
    Levy, Gabriel
    Guglielmelli, Paola
    Langmuir, Peter
    Constantinescu, Stefan
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (04)
  • [36] COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial
    Mancia, Giuseppe
    [J]. CARDIOVASCULAR RESEARCH, 2020, 116 (14) : E198 - E199
  • [37] The other possible mechanism of the benefits of RAAS inhibition in the athogenesis of COVID-19
    Gupta, Neelesh
    Patel, Krunalkumar
    Gupta, Rajeev
    [J]. CLINICAL CARDIOLOGY, 2020, 43 (12) : 1349 - 1349
  • [38] Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin-angiotensin-aldosterone system (RAAS) inhibitors: a systematic review
    Iheanacho, Chinonyerem O.
    Odili, Valentine U.
    Eze, Uchenna I. H.
    [J]. FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 7 (01)
  • [39] Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19
    Reynolds, Harmony R.
    Adhikari, Samrachana
    Pulgarin, Claudia
    Troxel, Andrea B.
    Iturrate, Eduardo
    Johnson, Stephen B.
    Hausvater, Anais
    Newman, Jonathan D.
    Berger, Jeffrey S.
    Bangalore, Sripal
    Katz, Stuart D.
    Fishman, Glenn I.
    Kunichoff, Dennis
    Chen, Yu
    Ogedegbe, Gbenga
    Hochman, Judith S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25): : 2441 - 2448
  • [40] THE RISK OF COVID-19 IS HIGHER IN FEMALES USING PROTON PUMP INHIBITORS
    Ghoneim, Sara
    Butt, Muhammad U.
    Saleh, Sherif
    Fass, Ronnie
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S436 - S436
12345